Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination.
Ocul Immunol Inflamm
; 29(4): 730-733, 2021 May 19.
Article
in English
| MEDLINE | ID: covidwho-1287901
ABSTRACT
Purpose:
To report acute macular neuroretinopathy (AMN) in two young women two days after receiving Vaxzevria Coronavirus disease (COVID-19) vaccination.Methods:
Observational case reports.Observation The first patient was an Italian 22-year-old female with acute onset of paracentral scotoma two days post vaccination. The second patient was an Austrian 28-year-old female who presented with sudden onset paracentral scotoma two days after vaccination. Multimodal retinal imaging was consistent with AMN in both cases. Both patients were on long-term oral contraceptives, had no history of COVID-19 and experienced one-day duration fever the day after the vaccination.Conclusions:
Vaccination may represent a possible risk factor for AMN onset in women on oral contraceptives. We encourage ophthalmologists to investigate recent vaccination status when dealing with new onset AMN. Further studies are needed to assess the link between vaccinations and AMN.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Retinal Vessels
/
Visual Acuity
/
Vaccination
/
White Dot Syndromes
/
COVID-19 Vaccines
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Ocul Immunol Inflamm
Journal subject:
Allergy and Immunology
/
Ophthalmology
Year:
2021
Document Type:
Article
Affiliation country:
09273948.2021.1946567
Similar
MEDLINE
...
LILACS
LIS